Results of Q fever research - Widespread in the media

22 March 2018

Several newspapers, including Algemeen Dagblad, Brabants Dagblad and De Gelderlander, opened on 15 March with articles about the research results concerning the long-term effects of Q fever. The NOS paid attention to this research on Radio 1 and in the national television news, just like Hart van Nederland and EenVandaag.

Researcher and epidemiologist Ellen van Jaarsveld of the department of Primary and Community Care, was also guest at the news bulletin of Omroep Brabant. The widespread media attention led, among other things, to the fact that the research was also discussed in the House of Representatives. Ellen investigated the long-term effects of 2600 Q fever patients with several colleagues from the academic workshop AMPHI (infectious diseases). Especially patients with chronic Q fever experience an increase in symptoms over the years, says Ellen. Fatigue increases and quality of life decreases. In patients with Q Fever Fatigue Syndrome (QVS), the study shows, that patients up to 8 years after acute Q fever infection continue to have many complaints and physical limitations. The results of the research were presented on 15 March in Eindhoven during the final conference of Q-support, the foundation for patients with Q Fever.

https://www.ad.nl/binnenland/onderzoek-naar-q-koorts-ondanks-behandeling-worden-klachten-alleen-maar-erger~a833e156/
https://eenvandaag.avrotros.nl/item/nieuw-onderzoek-klachten-van-q-koortspatienten-worden-erger/

Want to know more about these subjects? Click on the buttons below for more news.

RIHS Health Evidence Urological cancers

Related news items

Rob Aarnoutse is appointed as professor in Translation pharmacology of antimicrobial agents in particular drugs for tuberculosis

25 January 2021

Hospital pharmacist and clinical pharmacologist Rob Aarnoutse is appointed as professor in ‘Translation pharmacology of antimicrobial agents, in particular drugs for tuberculosis’ at Radboud University / Radboudumc, starting 16 November 2020.

Oral health research makes significant impact at the 148th WHO Executive Board meeting

25 January 2021

During the 148th session of the World Health Organization (WHO) Executive Board meeting, Member States passed a game-changing resolution on oral health. WHO Director General Dr Tedros Adhanom Ghebreyesus called it a “landmark resolution”.

Radiation boost lowers risk of prostate cancer recurrence

21 January 2021

An additional external-beam radiation dose delivered directly to the tumor can benefit the prospects of men with non-metastatic prostate cancer, without causing additional side effects. The risk of relapse within five years for these men is smaller than for men who did not receive this boost.

New research through grants for Radboudumc researchers

14 January 2021

Several researchers at the Radboudumc have received grants to start new studies, including on rare diseases, liver disease and cancer metastases. These are grants from the Dutch Research Council, European Joint Programme on Rare Diseases and the Gastric Liver Disease Foundation.

RIMLS online award ceremony proudly presenting the winners

13 January 2021

In this special webinar of the RIMLS New Year Celebration, scientific director René Bindels reviewed 2020 and looked forward to 2021. But more importantly a number of researchers received prizes in the traditional RIMLS awards ceremony.

Cooling vests alleviate perceptual heat strain perceived by COVID-19 nurses

11 January 2021

Wearing cooling vests during a COVID-19 shift ensures that nurses experience less heat during their work. The cooling vests offer such effective cooling that they are now part of the standard work clothing for nurses in the COVID nursing departments at Radboudumc.